When CTLA4 is overexpressed, the inhibitory signals produced exceed the immunogenicity provided by tumor cell surface antigens, downregulating or terminating T-cell activation, leading to immune escape of the tumor (30). This evidence concerns the gene CTLA4 and neoplasm.